Correlation Between Sartorius Aktiengesellscha and Sartorius Stedim

Can any of the company-specific risk be diversified away by investing in both Sartorius Aktiengesellscha and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Aktiengesellscha and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Aktiengesellschaft and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Sartorius Aktiengesellscha and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Aktiengesellscha with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Aktiengesellscha and Sartorius Stedim.

Diversification Opportunities for Sartorius Aktiengesellscha and Sartorius Stedim

0.61

Correlation Coefficient

Sartorius Aktiengesellscha  Sartorius Stedim

Poor diversification

The 3 months correlation between Sartorius and Sartorius is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Aktiengesellschaft and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Sartorius Aktiengesellscha is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Aktiengesellschaft are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Sartorius Aktiengesellscha i.e., Sartorius Aktiengesellscha and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Sartorius Aktiengesellscha and Sartorius Stedim

Assuming the 90 days trading horizon Sartorius Aktiengesellschaft is expected to under-perform the Sartorius Stedim. In addition to that, Sartorius Aktiengesellscha is 1.01 times more volatile than Sartorius Stedim Biotech. It trades about -0.02 of its total potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.02 per unit of volatility. If you would invest  28,984  in Sartorius Stedim Biotech on September 24, 2024 and sell it today you would lose (10,654) from holding Sartorius Stedim Biotech or give up 36.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sartorius Aktiengesellschaft  vs.  Sartorius Stedim Biotech

Sartorius Aktiengesellscha

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sartorius Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Sartorius Aktiengesellscha is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Sartorius Stedim Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Sartorius Aktiengesellscha and Sartorius Stedim

The main advantage of trading using opposite Sartorius Aktiengesellscha and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Aktiengesellscha position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.

The idea behind Sartorius Aktiengesellschaft and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.